Products

Merxin is active in the fields of pharmaceuticals and cannabinoid therapies (inhaled cannabinoid therapies iCTx).

MRX002+

DESIGNED FOR LOW CARBON FOOTPRINT pMDIS

MRX002+ DESIGNED FOR LOW CARBON FOOTPRINT pMDIS

MRX002+ is a see-through pMDI vial designed for low carbon footprint propellant formulations.

MRX002+ enables carbon neutral inhalers.

MRX002+ has been designed to be compatible with HFA 152a and...

EXPLORE MRX002+

MRX003

Capsule Dry Powder Inhaler

MRX003 Capsule Dry Powder Inhaler

MRX003 is a generic capsule based inhaler designed in particular as a generic AB rated device for tiotropium DPI.

It is developed for new molecules and the...

EXPLORE MRX003

MRX004

Soft mist inhaler

MRX004 Soft mist inhaler

MRX004 is a soft mist inhaler device. It is developed as an interchangeable AB rated device opportunity for tiotropium/olodaterol as formulated with the Respimat.

MRX004 is...

EXPLORE MRX004

MRX006

Multidose Dry Powder Inhaler

MRX006 Multidose Dry Powder Inhaler

Dual cavity for triple therapy dry powder inhaler (DPI). MRX006 is based on the open-inhale-close principle. It is suitable as an AB-rated substitutable device for triple combination...

EXPLORE MRX006
We use cookies only for marketing analytics
Close